Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor

Joseph Avruch, Xiaomeng Long, Yenshou Lin, Sara Ortiz-Vega, Joseph Rapley, Angela Papageorgiou, Noriko Oshiro, Ushio Kikkawa

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The signalling function of mTOR complex 1 is activated by Rheb-GTP, which controls the catalytic competence of the mTOR (mammalian target of rapamycin) kinase domain by an incompletely understood mechanism. Rheb can bind directly to the mTOR kinase domain, and association with inactive nucleotide-deficient Rheb mutants traps mTOR in a catalytically inactive state. Nevertheless, Rheb-GTP targets other than mTOR, such as FKBP38 (FK506-binding protein 38) and/or PLD1 (phospholipase D1), may also contribute to mTOR activation. Once activated, the mTOR catalytic domain phosphorylates substrates only when they are bound to raptor (regulatory associated protein of mTOR), a separate polypeptide within the complex. The mechanism of insulin/nutrient stimulation of mTOR complex 1 signalling, in addition to Rheb-GTP activation of the mTOR catalytic function, also involves a stable modification of the configuration of mTORC1 (mTOR complex 1) that increases access of substrates to their binding site on the raptor polypeptide. The mechanism underlying this second step in the activation of mTORC1 is unknown.

Original languageEnglish
Pages (from-to)223-226
Number of pages4
JournalBiochemical Society Transactions
Volume37
Issue number1
DOIs
Publication statusPublished - 2009 Jun 26

Fingerprint

TOR Serine-Threonine Kinases
Sirolimus
Guanosine Triphosphate
Chemical activation
Substrates
Phosphotransferases
Tacrolimus Binding Proteins
Peptides
Mental Competency
Catalytic Domain
Nutrients
Nucleotides
Binding Sites
Insulin
Food
Association reactions

Keywords

  • Insulin
  • Leucine
  • Mammalian target of rapamycin (mTOR)
  • Regulatory associated protein of mTOR (raptor)
  • Rheb
  • Tuberous sclerosis complex (TSC)

ASJC Scopus subject areas

  • Biochemistry

Cite this

Activation of mTORC1 in two steps : Rheb-GTP activation of catalytic function and increased binding of substrates to raptor. / Avruch, Joseph; Long, Xiaomeng; Lin, Yenshou; Ortiz-Vega, Sara; Rapley, Joseph; Papageorgiou, Angela; Oshiro, Noriko; Kikkawa, Ushio.

In: Biochemical Society Transactions, Vol. 37, No. 1, 26.06.2009, p. 223-226.

Research output: Contribution to journalArticle

Avruch, Joseph ; Long, Xiaomeng ; Lin, Yenshou ; Ortiz-Vega, Sara ; Rapley, Joseph ; Papageorgiou, Angela ; Oshiro, Noriko ; Kikkawa, Ushio. / Activation of mTORC1 in two steps : Rheb-GTP activation of catalytic function and increased binding of substrates to raptor. In: Biochemical Society Transactions. 2009 ; Vol. 37, No. 1. pp. 223-226.
@article{d839c75cc2314e46a135a2703d618a01,
title = "Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor",
abstract = "The signalling function of mTOR complex 1 is activated by Rheb-GTP, which controls the catalytic competence of the mTOR (mammalian target of rapamycin) kinase domain by an incompletely understood mechanism. Rheb can bind directly to the mTOR kinase domain, and association with inactive nucleotide-deficient Rheb mutants traps mTOR in a catalytically inactive state. Nevertheless, Rheb-GTP targets other than mTOR, such as FKBP38 (FK506-binding protein 38) and/or PLD1 (phospholipase D1), may also contribute to mTOR activation. Once activated, the mTOR catalytic domain phosphorylates substrates only when they are bound to raptor (regulatory associated protein of mTOR), a separate polypeptide within the complex. The mechanism of insulin/nutrient stimulation of mTOR complex 1 signalling, in addition to Rheb-GTP activation of the mTOR catalytic function, also involves a stable modification of the configuration of mTORC1 (mTOR complex 1) that increases access of substrates to their binding site on the raptor polypeptide. The mechanism underlying this second step in the activation of mTORC1 is unknown.",
keywords = "Insulin, Leucine, Mammalian target of rapamycin (mTOR), Regulatory associated protein of mTOR (raptor), Rheb, Tuberous sclerosis complex (TSC)",
author = "Joseph Avruch and Xiaomeng Long and Yenshou Lin and Sara Ortiz-Vega and Joseph Rapley and Angela Papageorgiou and Noriko Oshiro and Ushio Kikkawa",
year = "2009",
month = "6",
day = "26",
doi = "10.1042/BST0370223",
language = "English",
volume = "37",
pages = "223--226",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",
number = "1",

}

TY - JOUR

T1 - Activation of mTORC1 in two steps

T2 - Rheb-GTP activation of catalytic function and increased binding of substrates to raptor

AU - Avruch, Joseph

AU - Long, Xiaomeng

AU - Lin, Yenshou

AU - Ortiz-Vega, Sara

AU - Rapley, Joseph

AU - Papageorgiou, Angela

AU - Oshiro, Noriko

AU - Kikkawa, Ushio

PY - 2009/6/26

Y1 - 2009/6/26

N2 - The signalling function of mTOR complex 1 is activated by Rheb-GTP, which controls the catalytic competence of the mTOR (mammalian target of rapamycin) kinase domain by an incompletely understood mechanism. Rheb can bind directly to the mTOR kinase domain, and association with inactive nucleotide-deficient Rheb mutants traps mTOR in a catalytically inactive state. Nevertheless, Rheb-GTP targets other than mTOR, such as FKBP38 (FK506-binding protein 38) and/or PLD1 (phospholipase D1), may also contribute to mTOR activation. Once activated, the mTOR catalytic domain phosphorylates substrates only when they are bound to raptor (regulatory associated protein of mTOR), a separate polypeptide within the complex. The mechanism of insulin/nutrient stimulation of mTOR complex 1 signalling, in addition to Rheb-GTP activation of the mTOR catalytic function, also involves a stable modification of the configuration of mTORC1 (mTOR complex 1) that increases access of substrates to their binding site on the raptor polypeptide. The mechanism underlying this second step in the activation of mTORC1 is unknown.

AB - The signalling function of mTOR complex 1 is activated by Rheb-GTP, which controls the catalytic competence of the mTOR (mammalian target of rapamycin) kinase domain by an incompletely understood mechanism. Rheb can bind directly to the mTOR kinase domain, and association with inactive nucleotide-deficient Rheb mutants traps mTOR in a catalytically inactive state. Nevertheless, Rheb-GTP targets other than mTOR, such as FKBP38 (FK506-binding protein 38) and/or PLD1 (phospholipase D1), may also contribute to mTOR activation. Once activated, the mTOR catalytic domain phosphorylates substrates only when they are bound to raptor (regulatory associated protein of mTOR), a separate polypeptide within the complex. The mechanism of insulin/nutrient stimulation of mTOR complex 1 signalling, in addition to Rheb-GTP activation of the mTOR catalytic function, also involves a stable modification of the configuration of mTORC1 (mTOR complex 1) that increases access of substrates to their binding site on the raptor polypeptide. The mechanism underlying this second step in the activation of mTORC1 is unknown.

KW - Insulin

KW - Leucine

KW - Mammalian target of rapamycin (mTOR)

KW - Regulatory associated protein of mTOR (raptor)

KW - Rheb

KW - Tuberous sclerosis complex (TSC)

UR - http://www.scopus.com/inward/record.url?scp=59749090661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59749090661&partnerID=8YFLogxK

U2 - 10.1042/BST0370223

DO - 10.1042/BST0370223

M3 - Article

C2 - 19143636

AN - SCOPUS:59749090661

VL - 37

SP - 223

EP - 226

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

IS - 1

ER -